Efficacy of Percutaneous Tenotomy in Chronic Lateral Epicondylitis Over Time

  • Anu Kumar Changkum MS Orthopaedics, Dr. RPGMC Kangra at Tanda.
  • Akshay Sharma MS Orthopaedics, Dr. RPGMC Kangra at Tanda.
  • Ashish Meena MS Orthopaedics, Dr RPGMC Kangra at Tanda.
  • Vipin Sharma Professor and Head, Department of Orthopaedics, Dr. RPGMC Kangra at Tanda.
DOI: https://doi.org/10.32553/jbpr.v13i2.1078
Keywords: Functional recovery

Abstract

Background: Chronic lateral epicondylitis significantly impacts individuals' quality of life by causing persistent elbow pain and limited grip strength. Percutaneous tenotomy offers a promising approach to address this condition, yet its long-term efficacy remains underexplored.

Methods: This retrospective study assessed 45 patients who underwent percutaneous tenotomy for chronic lateral epicondylitis. Pain and functional outcomes were evaluated using NRS, DASH, and Oxford scores over a 36-month follow-up period.

Results: Significant improvements were observed in all outcome measures across the follow-up period, indicating sustained pain relief, functional recovery, and enhanced quality of life post-tenotomy.

Conclusion: Percutaneous tenotomy proves to be an effective and durable treatment for chronic lateral epicondylitis, offering significant benefits in terms of pain reduction and functional improvement over time.

Keywords: Chronic lateral epicondylitis, Percutaneous tenotomy, Long-term efficacy, Pain relief, Functional recovery.

Published
2024-04-08
How to Cite
Changkum , A. K., Sharma , A., Meena, A., & Sharma, V. (2024). Efficacy of Percutaneous Tenotomy in Chronic Lateral Epicondylitis Over Time. Journal of Biomedical and Pharmaceutical Research, 13(2), 23-27. https://doi.org/10.32553/jbpr.v13i2.1078
Issue
Vol. 13 No. 2 (2024)
Section
Articles

Copyright (c) 2024 Journal of Biomedical and Pharmaceutical Research

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Creative Commons LicenseJournal of Biomedical and Pharmaceutical Research by Articles is licensed under a Creative Commons Attribution 4.0 International License.